Clinical Supply Services
Clinical Supply Services
PI Health Sciences delivers comprehensive Clinical Supply Services designed to support Phase 1, 2, and 3 clinical trials with reliable, compliant, and scalable manufacturing solutions. Our global infrastructure across India and Italy enables coordinated supply execution, ensuring timely delivery of high-quality clinical materials aligned with international regulatory expectations. From active pharmaceutical ingredients to finished dosage forms, our clinical supply model is structured to provide phase specific manufacturing solutions tailored to the unique demands of each trial stage. We integrate process standardization, quality governance, and flexible production strategies to maintain consistency, compliance, and operational precision throughout clinical development. Through transparent communication and lifecycle focused collaboration, we support clinical programs with structured regulatory alignment and dedicated global coordination.Capabilities
End to End Clinical Supply Manufacturing
We provide comprehensive manufacturing services spanning APIs to finished dosage forms. Our integrated model supports clinical packaging, labeling, and distribution within a coordinated supply framework aligned to trial timelines.
Phase Specific Clinical Supply Solutions
Customized manufacturing and supply strategies are developed for Phase 1, 2, and 3 trials. Production planning and execution are tailored to meet evolving clinical study requirements while maintaining regulatory alignment.
Scalable Production & Process Standardization
Optimized scale up strategies and consistent process control ensure reproducibility and reliability across clinical phases. Flexible production scales support both small early phase batches and larger Phase 3 supply needs.
Quality & Regulatory Governance
Operations adhere to GMP, ICH Q7, and global regulatory expectations. Structured quality oversight ensures compliance across manufacturing, packaging, and supply activities supporting international clinical programs.
Global Infrastructure & HPAPI Capability
Facilities in India and Italy enable coordinated global supply management. Specialized handling capabilities support HPAPIs and complex formulations within a compliant clinical manufacturing environment.
Frequently asked questions
We’re here to help with any questions you have about our plans, supported features, and how our model works.
What does our Clinical Supply Services include?
Our Clinical Supply Services cover the full spectrum of manufacturing and supply requirements for Phase 1, 2, and 3 clinical trials. This includes production of active pharmaceutical ingredients, finished dosage forms, clinical packaging, labeling, and coordinated distribution. The integrated model ensures that materials are manufactured, controlled, and delivered in alignment with clinical study timelines and regulatory expectations. By consolidating these activities within a unified framework, we support efficient and compliant clinical trial execution.
How are supplies tailored for different clinical phases?
Clinical trials at different phases require varying production scales, documentation standards, and regulatory controls. Our phase specific supply model adapts manufacturing strategies to the unique needs of each trial stage. Early phase trials may require smaller batch sizes and rapid turnaround, while later phase programs demand larger volumes and increased process consistency. Our structured planning ensures that each phase receives appropriately scaled, compliant, and well documented supply solutions.
What quality standards govern our clinical supply operations?
Our clinical supply manufacturing operations adhere to GMP, ICH Q7, and international regulatory expectations. Quality governance is embedded throughout manufacturing, packaging, and distribution processes. Structured process controls, documentation practices, and regulatory alignment ensure that materials are produced consistently and are suitable for global clinical programs.
Do we support HPAPIs and complex formulations in clinical supply?
We provide specialized handling capabilities for HPAPIs and complex formulations within a compliant manufacturing environment. Our processes are structured to ensure controlled production, regulatory adherence, and consistent quality across clinical phases. This enables safe and reliable execution of clinical manufacturing programs involving high potency or technically demanding compounds.
How does our global infrastructure support international clinical trials?
With facilities in India and Italy, we maintain a coordinated global supply network that supports international clinical trial requirements. This infrastructure enables efficient supply chain management, continuous operational support, and alignment with diverse regulatory expectations. Our integrated global execution model ensures timely delivery and consistent quality across multiple regions and clinical development stages.
Contact Us
Connect with PI Health Sciences to explore how our pre-clinical services de-risk development and prepare therapeutic candidates for IND submission with precision and scientific rigor.